Effect of SSP-004184 (SPD602) on the Pharmacokinetics of Simvastatin in Healthy Adult Subjects
NCT01979185 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2021-06-24
Summary
This is a randomized, open-label study to evaluate the effect of a single dose of SSP-004184 on the pharmacokinetics of a single dose of simvastatin in healthy adult subjects.
Conditions
- Healthy
Interventions
- DRUG
-
Simvastatin
- DRUG
-
SSP-004184SS
Sponsors & Collaborators
-
Shire
lead INDUSTRY
Principal Investigators
-
Study Director · Takeda
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-11-18
- Primary Completion
- 2013-12-13
- Completion
- 2013-12-13
Countries
- United States
Study Locations
More Related Trials
-
The Effects of Ezetimibe/Simvastatin 10/20 mg Versus Simvastatin 40 mg in High Cholesterol and Coronary Heart Disease Study (P04039AM2)(COMPLETED)
NCT00423579 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)
NCT00092157 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia
NCT00141141 ·Status: COMPLETED ·Phase: PHASE4
-
A Drug Interaction Study Between Simvastatin and GSK376501
NCT00605449 ·Status: COMPLETED ·Phase: PHASE1
-
Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED)
NCT00935259 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Interaction Study Between TMC435, Atorvastatin and Simvastatin in Healthy Participants
NCT01689623 ·Status: COMPLETED ·Phase: PHASE1
-
An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia
NCT00487591 ·Status: COMPLETED
-
Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)
NCT00409773 ·Status: COMPLETED ·Phase: PHASE3
-
Multiple Ascending Dose and DDI Study
NCT03031119 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor 20mg/Glucophage SR 750mg
NCT02378441 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD6615 in Healthy Subjects
NCT04055168 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)
NCT00535405 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
NCT00688558 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia
NCT00686010 ·Status: COMPLETED ·Phase: PHASE2
-
MK0524B Bioequivalence Study (0524B-070)
NCT00943124 ·Status: COMPLETED ·Phase: PHASE1
-
Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED)
NCT00782184 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia
NCT06238466 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors
NCT02977065 ·Status: COMPLETED ·Phase: PHASE2
-
A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins
NCT01342211 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Co-Administered AZD9056 (Steady State) and Simvastatin (Single Dose) in Healthy Volunteers
NCT00736606 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin
NCT01218204 ·Status: COMPLETED ·Phase: PHASE2
-
A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol
NCT01004705 ·Status: TERMINATED ·Phase: PHASE2
-
Investigate the Effect of Ezetimibe, Simvastatin, and Omega 3- Fatty Acids on Dyslipidemia Patients: a Pharmacokinetics Based Study
NCT05080140 ·Status: UNKNOWN
-
The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal Subjects
NCT01486433 ·Status: COMPLETED ·Phase: PHASE1
-
Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment
NCT00819403 ·Status: COMPLETED ·Phase: PHASE4